40. 高安動脈炎 Takayasu arteritis Clinical trials / Disease details

臨床試験数 : 25 / 薬物数 : 50 - (DrugBank : 21) / 標的遺伝子数 : 25 - 標的パスウェイ数 : 114

3 trials found

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04564001 (ClinicalTrials.gov)	September 2020	21/9/2020	Multicentre, Randomized, Prospective Trial Evaluating the Efficacy and Safety of Infliximabto Tocili ...	Multicentre, Randomized, Prospective Trial Evaluating the Efficacy and Safety of Infliximabto Tocili ...	Takayasu Arteritis	Drug: Infliximab;Drug: Tocilizumab	Assistance Publique - Hôpitaux de Paris	NULL	Not yet recruiting	18 Years	N/A	All	50	Phase 2	NULL
2	EUCTR2018-003753-13-FR (EUCTR)	19/03/2019	13/12/2018	INTOReTAK : INfliximab and TOcilizumab in Refractory/relapsing TAKayasu arteritis	Multicentre, randomized, prospective trial comparing the efficacy and safety of Infliximabto tociliz ...	Patients with refractory or relapsing Takayasu Arteritis desease;Therapeutic area: Analytical, Diagn ...	Trade Name: RoActemra 20mg/ml Product Name: Tocilizumab INN or Proposed INN: Tocilizumab Other descripti ...	ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	50	Phase 3	France
3	NCT03192878 (ClinicalTrials.gov)	March 1, 2017	9/5/2017	Infliximab Biosimilar in Takayasu's Arteritis	A Prospective Observational Study of InfliximabBiosimilar in the Treatment of Takayasu's Arteritis R ...	Takayasu Arteritis	Drug: Infliximab	Ospedale San Raffaele	NULL	Recruiting	18 Years	N/A	All	30	N/A	Italy

First Previous1Next Last